Clinical Trial Update: Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF [Phase 4]

View source ↗

Summary

Phase 4 pilot study evaluating deprescribing beta-blockers using N-of-1 trials in patients with heart failure with preserved ejection fraction (HFpEF).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• beta-blockers (beta-adrenergic blocker)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Heart Failure, Heart Failure, Diastolic | Phase 4 | Status: COMPLETED | Results posted: 2024-04-09